Bashan Dror insider trades
Bashan Dror has filed 9 Form 4s with the SEC that we hold, all for Protalix BioTherapeutics, Inc. (PLX), as PRESIDENT AND CEO, Director. Across all of them we count 4 purchases worth $293.8K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($101.4K) and 0 sales ($0). The largest single trade was a purchase of 68,000 shares of Protalix BioTherapeutics, Inc. worth $102.0K, dated 2022-04-11. The first filing on our record is dated 2022-02-28 and the latest 2026-09-04.
Protalix BioTherapeutics, Inc. (PLX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-11 | P, purchase reported on Form 4 | 68,000 | $102.0K | 2022-04-13 |
| 2023-10-19 | P, purchase reported on Form 4 | 16,129 | $22.7K | 2023-10-20 |
| 2023-10-19 | P, purchase reported on Form 4 | 48,387 | $67.7K | 2023-10-20 |
| 2025-12-19 | P, purchase reported on Form 4 | 56,000 | $101.4K | 2025-12-23 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1781450) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms